Navigation Links
QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Date:9/24/2009
SYDNEY, Australia and BEDMINSTER, N.J., Sept. 24 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and Pink Sheets: QRXPY), announced today a strategic alliance with Liaoning Nuokang Medicines Co. Ltd. ("Nuokang"), a Chinese biopharmaceutical company based in Shenyang, China, to develop and commercialise QRxPharma's venomics assets for the Chinese market. The strategic alliance involves Nuokang investing US$5.0 million for a controlling interest in a Hong Kong company that holds a license over two of QRxPharma's lead haemostasis product candidates: Textilinin, an antifibrinolytic agent, and Haempatch(TM), a potent pro-coagulant.
The transaction is expected to be completed by mid October 2009. On completion, a minority interest in the Hong Kong company will be held by Venomics Pty Ltd, which is a majority-owned subsidiary of QRxPharma and holds all of the venomics assets of QRxPharma. An affiliated company of Nuokang has also subscribed to a 10% interest in Venomics Pty Limited.
"We are very pleased to announce the strategic alliance of QRxPharma's venomics program with a leading Chinese biopharmaceutical company that has extensive experience in the development, manufacture and sale of therapeutics derived from snake venoms," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "Blood loss in surgery and trauma is a significantly under-served market opportunity, and Nuokang's capabilities and resources will ensure that Textilinin and Haempatch(TM) progress quickly to the clinic."
Dr. Holaday further said that he was particularly pleased to have concluded this deal:
"This strategic alliance provides a great opportunity to extract value for QRxPharma shareholders from the venomics assets without diverting management's attention away from QRxPharma's main prospect with its Dual Opioid(TM) development programme in the area of pain management".<
'/>"/>
| SOURCE QRxPharma Limited Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President
2. QRxPharma Begins Trading on the International OTCQX
3. QRxPharma Initiates Second Phase III Clinical Trial for its Dual Opioid Pain Therapy
4. I-Therapeutix, Inc. Announces Company Name Change
5. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
7. US Farms, Inc. Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products
8. ReBuilder Medical Technologies, Inc. Announces Medicare Billing Ability for its ReBuilder Product
9. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
10. Strategic Information Group Announces QAD Enterprise Validation Partnership
11. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
Post Your Comments:
(Date:5/24/2013)... In a coup that surely made other Palm ... the Estetica Institute of the Palm Beaches performed eye surgeries ... morning show, “The Mo & Sally Morning Show.” The DJ’s ... with the results, giving Dr. DeLange and the team at ... Gardens, very valuable free publicity. , Dr. DeLange, the owner ...
(Date:5/24/2013)... FL (PRWEB) May 24, 2013 The producers ... May air dates for Charlotte, North Carolina. It is one ... many Fortune 500 companies. The city is populated with more ... organizations which cover residents in both North and South Carolina. ... all things medically-related can tune into WAXN-TV 64 Eyewitness News ...
(Date:5/24/2013)... 24, 2013 Fit Yummy Mummy, a ... mothers who are trying to get rid of the ... is ideal for women who want to combine exercises ... ’s Stan Stevenson, prompting an investigative review. , ... contains a wide variety of motivational strategies, nutritional plans, ...
(Date:5/24/2013)... GA (PRWEB) May 24, 2013 CBT News.com ... Sales. Gonter joins the web-based retail automotive industry news organization ... , “I’m excited to join a group that’s so ... perfect example of how online video content is on the ... in the motorcycle business and segued into advertising at Cycle ...
(Date:5/24/2013)... Residents of San Diego have a new ... expert, and Certified Russian Kettlebell Instructor, Cody Bramlett has ... San Diego, California. The classes take place Monday through ... Initial sign-ups are available online and by clicking ... for years. The bootcamps being offered in San ...
Breaking Medicine News(10 mins):Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2[0] Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team[0] Health Briefs TV Presents May Air Dates for Charlotte, North Carolina[0] Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released[0] Tom Gonter to Drive Sales at Retail Automotive News Organization CBT News[0] Kettlebell X Bootcamp Now Offered Six Days A Week in San Diego
... regulation of body weight suggests a potential mechanism underlying ... of two competing hypotheses of weight regulation. In ... General Hospital (MGH) investigators outline a system in which ... animal,s weight tends to gravitate, rather than a single ...
... R. Hill has been appointed,Interim President and CEO of ... to accept a position as president of HealthAmerica,s,Central Pennsylvania ... ) , Hill,s selection ... board of directors. , "The ...
... who allegedly was seriously injured by Medtronic, Inc.,s Infuse(R) ... by Medtronic has sued the company, according to James ... LLC.The firms, along with co-counsel Lieff, Cabraser, Heimann & ... on behalf of Paul and Susan Antonelli, of Amsterdam, ...
... too different from others , , WEDNESDAY, Jan. 14 ... go along with popular opinion in social situations, a ... resonance imaging showed that people whose opinion differed with ... response in the brain,s rostral cingulate zone (RCZ) and ...
... National Cancer Coalition (NCC) and Wyeth Pharmaceuticals (Wyeth) ... assist cancer patients in Latin America with donations ... injection) and Neumega(TM) (oprelvekin). United States Ambassador Michael ... a hand-over event held at the Instituto Nacional ...
... oust reformers, local union officers unopposedOAKLAND, Calif., Jan. ... Rosselli and all 17 other statewide officers were ... chair Debby Schneider. Their victory comes despite a ... to oust reformers in the local union from ...
Cached Medicine News:Health News:New model system may better explain regulation of body weight 2Health News:New model system may better explain regulation of body weight 3Health News:HealthPlus Names Bruce Hill Interim President and CEO 2Health News:Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC 2Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:United Healthcare Workers Re-Elect All Statewide Officers 2New model system may better explain regulation of body weightHealthPlus Names Bruce Hill Interim President and CEOMedtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLCBrain May Be Wired for Social ConformityNCC and Wyeth Donation to Assist Cancer Patients in Latin AmericaUnited Healthcare Workers Re-Elect All Statewide Officers
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 ... un destacado desarrollador y fabricante de herramientas de ... diagnosis y tratamiento de la enfermedad vascular periférica ... ensayo ADVISE ( Ad enosine V asodilator ... valuation) II durante la sesión de ensayo clínico ...
(Date:5/23/2013)... 2013 Haemonetics Corporation (NYSE: HAE ) announced ... EVP-Business Development, will present at The Deutsche Bank 38 th ... MA on May 29, 2013 at 1:30pm Eastern ... The public may access Mr. Lindop,s presentation live via ... Haemonetics (NYSE: HAE ) is a ...
(Date:5/23/2013)... May 23, 2013 MGC Diagnostics Corporation (NASDAQ: ... technology company, today scheduled a conference call to discuss ... year 2013, ended April 30, 2013. The call will ... 2013. The Company will report financial results for the ... close on Thursday, May 30, 2013. ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2[0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2[0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference[0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013
... 24 Kewaunee Scientific Corporation (Nasdaq: KEQU ) ... July 31, 2010. Sales for the quarter were ... quarter of the prior year. This was primarily the result ... mid-sized laboratory projects and the scheduled timing of shipments in ...
... 24 Women and men with a 10-year cardiovascular ... cholesterol levels but high levels of hsCRP, a protein ... statin therapy, according to new research. (Logo: ... ) The study, published in ...
Cached Medicine Technology:Kewaunee Scientific Reports Sales and Earnings for First Quarter 2Kewaunee Scientific Reports Sales and Earnings for First Quarter 3Kewaunee Scientific Reports Sales and Earnings for First Quarter 4People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal 2People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal 3People at 'Intermediate Risk' of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal 4... evaluation of pancreatic -cell function is not only ... of the natural history of diabetes mellitus, but ... guide to the correct choice of treatment. Peripheral ... function because of the large and variable uptake ...
... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |